eNauka - pregled
Pregled prema Projekat Merck KGaA, Darmstadt, Germany
Prikaz rezultata 1 do 6 od 6
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2024 | Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial | Reck, Martin; ...; Andric, Zoran G   ; ...; (broj, koautora 18) | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2014 | Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial | Stupp, Roger; ...; Grujicic, Danica M; ...; (broj, koautora 37) | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2012 | Efficacy and safety of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis: Further outcomes from the IMPROVE study | De, Stefano Nicola; Sormani, Maria Pia; Stubinski, Bettina; Blevins, Gregg; Drulovic, Jelena S ; Issard, Delphine; Shotekov, Penko; Gasperini, Claudio | Naučni članak | 22M22 - Međunarodni časopis kategorije M22 |
| 2021 | First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC) | Andric, Zoran G ; ...; Stojanovic, Goran; Petrovic, Marina D ; ...; (broj, koautora 20) | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2018 | Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer | Van, Cutsem Eric; Hidalgo, Manuel; Canon, Jean-Luc; Macarulla, Teresa; Bazin, Igor; Poddubskaya, Elena; Manojlović, Nebojša S. ; Radenkovic, Dejan V; Verslype, Chris; Eric, Raymond;
Cubillo, Antonio; Schueler, Armin; Zhao, Charles; Hammel, Pascal;
| Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
| 2015 | Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study | Nabors, Louis Burt; ...; Grujicic, Danica M; ...; (broj, koautora 17) | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |